CohBar (NASDAQ: CWBR)
$0.80
(-11.2%)
-$0.10
Price as of April 24, 2024, 1:54 p.m. ET
CohBar Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
CohBar Company Info
CohBar, Inc. is a clinical stage biotechnology company, which engages in the research and development of mitochondria-based therapeutics targeting chronic and age-related diseases. The company was founded by Nir Barzilai, Pinchas Cohen, David Sinclair, John Amatruda, and Laura Cobb on October 19, 2007 and is headquartered in Menlo Park, CA.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.